Read all about it! The latest news from the medical technology experts

Ingeneus CEO, Richard Walmsley is pleased to announce that Patents have now been issued in Australia, the US and China for both the eyeConnect and the eyePressure devices.

“With Patents recently issued for the eyePressure device in Australia and in the US, it is very pleasing to now have patents in three major countries for both the eyeConnect and eyePressure products,” Mr Walmsley said.

1 - Patents issued in key regions for the eyeTelehealth Platform

“These are large and important markets and these Patents add further credibility to the products. The Patents will assist in the marketing of these devices as ‘first of kind’ in these countries,” he said.

“A patent for the eyePressure device in Vietnam has also been issued.”

The eyeConnect and eyePressure devices form part of the eyeTelehealth Platform that fulfils a global need by allowing minimally trained operators in Primary Healthcare settings such as Emergency Departments or a screening setting, to easily capture critical data about a patient's eye and then transmit this data to a remote specialist for assessment.

The key products that form the eyeTelehealth Platform are:

• eyeConnect – a remote telehealth eye assessment system that collects information including: patient history, acuity test results, intra-ocular pressure assessment and high resolution photographs

• eyePressure – a disposable eye pressure assessment device, and

• eyeTelecloud – secure cloud environment that allows authorised personnel to access, view and report on patient data from eyeConnect systems.

For more information please email enquiries@ingeneus.com.au or call +61 3 9558 6334.